Orthocort 6 Tablet contains Deflazacort 6 mg, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is indicated for the management of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, allergic disorders, and certain dermatological diseases. Deflazacort exerts its therapeutic effects by modulating the immune response and inhibiting the release of pro-inflammatory mediators, thereby reducing inflammation, swelling, and pain. Orthocort 6 is also utilized in the treatment of certain muscular dystrophies to improve muscle strength and function. The tablet formulation allows for convenient oral administration with predictable absorption and bioavailability. Dosage and duration of therapy should be individualized based on the patient’s clinical condition, response to treatment, and tolerance, with careful monitoring to minimize potential adverse effects such as hyperglycemia, osteoporosis, hypertension, and increased susceptibility to infections. Abrupt discontinuation should be avoided to prevent adrenal insufficiency; tapering is recommended when discontinuing long-term therapy. Orthocort 6 should be used under strict medical supervision, particularly in patients with comorbidities such as diabetes, hypertension, or peptic ulcer disease. Regular follow-up and laboratory assessments are advised to ensure safe and effective use of this corticosteroid medication.